0001209191-20-042292.txt : 20200713 0001209191-20-042292.hdr.sgml : 20200713 20200713165020 ACCESSION NUMBER: 0001209191-20-042292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200713 FILED AS OF DATE: 20200713 DATE AS OF CHANGE: 20200713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Branning Todd P. CENTRAL INDEX KEY: 0001765274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39094 FILM NUMBER: 201025648 MAIL ADDRESS: STREET 1: C/O AMNEAL PHARMACEUTICLAS, INC. STREET 2: 400 CROSSING BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001783183 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824151574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE, STREET 2: SUITE 102 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (877) 742-8466 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE, STREET 2: SUITE 102 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-13 0 0001783183 Phathom Pharmaceuticals, Inc. PHAT 0001765274 Branning Todd P. C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 29.43 2020-07-13 4 A 0 85000 0.00 A 2030-07-12 Common Stock 85000 85000 D The option will vest with respect to one-fourth of the shares of common stock on July 13, 2021, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates. /s/ Larry Miller, Attorney-in-Fact for Todd Branning 2020-07-13